Survival with pancreatic cancer depends on several factors including stage at diagnosis, metastatic spread, tumor biology, and treatment response. Patients diagnosed at earlier stages generally have better outcomes because surgery may still be possible. Advanced pancreatic cancer remains one of the most aggressive cancer types worldwide. However, modern targeted therapies, FDA-backed drugs, and immunotherapy research are improving survival expectations for some patients. Early intervention and comprehensive medical management remain critical for prognosis.